Comparative study of different sources of Pertussis Toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays

Clinical and Vaccine Immunology

Volumn 19, Issue 1, 2012, Pages 64-72

  Kapasi, Aditi ^a   Meade, Bruce D ^e   Plikaytis, Brian ^a   Pawloski, Lucia ^a   Martin, Monte D ^a   Yoder, Sandra ^b   Rock, Michael T ^b   Coddens, Séverine ^d   Haezebroeck, Valérie ^d   Fievet Groyne, Françoise ^d   Bixler, Garvin ^c   Jones, Charles ^c   Hildreth, Stephen ^c   Edwards, Kathryn M ^b   Messonnier, Nancy E ^a   Tondella, Maria L ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c SANOFI PASTEUR   (France)

^d GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^e Meade Biologics LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PERTUSSIS TOXIN;

ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BORDETELLA PERTUSSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; PERTUSSIS; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; SERODIAGNOSIS;

ADULT; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CHILD, PRESCHOOL; CLINICAL LABORATORY TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; INFANT; PERTUSSIS TOXIN; REPRODUCIBILITY OF RESULTS; WHOOPING COUGH;

EID: 84855661429     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05460-11     Document Type: Article

References (30)

1. Andre P, et al. 2008. Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007. J. Clin. Microbiol. 46:1672-1677. (Pubitemid 351657212)
2. Baughman AL, et al. 2004. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin. Diagn. Lab. Immunol. 11:1045-1053. (Pubitemid 39540842)
3. CDC. 2007. Outbreaks of respiratory illness mistakenly attributed to pertussis - New Hampshire, Massachusetts, and Tennessee, 2004-2006. MMWR Morb. Mortal. Wkly. Rep. 56:837-842.
4. CDC. 2006. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 55:1-34.
5. CDC. 2006. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm. Rep. 55:1-37.
6. Cherry JD, Gornbein J, Heininger U, Stehr K. 1998. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16:1901-1906. (Pubitemid 28473933)
7. Cherry JD, et al. 2010. Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis. Clin. Vaccine Immunol. 17:741-747.
8. Cornbleet PJ, Gochman N. 1979. Incorrect least-squares regression coefficients in method-comparison analysis. Clin. Chem. 25:432-438. (Pubitemid 9142871)
9. Dalby T, Petersen JW, Harboe ZB, Krogfelt KA. 2010. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine. J. Med. Microbiol. 59:1029-1036.
10. de Melker HE, et al. 2000. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J. Clin. Microbiol. 38:800-806.
11. Edwards KM. 2005. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr. Infect. Dis. J. 24:S104-S108. (Pubitemid 40840106)
12. Fry NK, et al. 2004. Laboratory diagnosis of pertussis infections: the role of PCR and serology. J. Med. Microbiol. 53:519-525. (Pubitemid 38803047)
13. Giammanco A, et al. 2003. European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine 22:112-120. (Pubitemid 37357158)
14. Giammanco A, et al. 2008. European Sero-Epidemiology Network 2: standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations. Vaccine 26:4486-4493.
15. Guiso N, et al. 2011. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur. J. Clin. Microbiol. Infect. Dis. 30:307-312.
16. Lin LI. 1989. A concordance correlation coefficient to evaluate reproducibility. Biometrics 45:255-268.
17. Lynn F, Reed GF, Meade BD. 1996. Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens. Clin. Diagn. Lab Immunol. 3:689-700. (Pubitemid 26388804)
18. Madore DV, Meade BD, Rubin F, Deal C, Lynn F. 2010. Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroads. Vaccine 28:4539-4547.
19. Marchant CD, et al. 1994. Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness. J. Infect. Dis. 169:1297-1305. (Pubitemid 24164594)
20. Meade BD, et al. 1995. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics 96:570-575.
21. Menzies SL, et al. 2009. Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection. Clin. Vaccine Immunol. 16:1781-1788.
22. Mooi FR, Hallander H, Wirsing von Konig CH, Hoet B, Guiso N. 2000. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur. J. Clin. Microbiol. Infect. Dis. 19:174-181. (Pubitemid 30201292)
23. Okada K, et al. 2004. Seroepidemiologic study on pertussis, diphtheria, and tetanus in the Fukuoka area of southern Japan: seroprevalence among persons 0-80 years old and vaccination program. Jpn. J. Infect. Dis. 57:67-71. (Pubitemid 38679056)
24. Storsaeter J, Hallander HO, Gustafsson L, Olin P. 1998. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16:1907-1916. (Pubitemid 28473934)
25. Tondella ML, et al. 2009. International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007. Vaccine 27:803-814.
26. von Konig CH, Halperin S, Riffelmann M, Guiso N. 2002. Pertussis of adults and infants. Lancet Infect. Dis. 2:744-750. (Pubitemid 35434559)
27. Wei SC, et al. 2010. Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis. Clin. Infect. Dis. 51:315-321.
28. Wendelboe AM, Van Rie A. 2006. Diagnosis of pertussis: a historical review and recent developments. Expert Rev. Mol. Diagn. 6:857-864. (Pubitemid 44904001)
29. Xing D, et al. 2011. EUVAC.NET collaborative study: evaluation and standardisation of serology for diagnosis of pertussis. J. Immunol. Methods 372:137-145.
30. Xing D, et al. 2009. Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study. Clin. Vaccine Immunol. 16:303-311.